Expasy logo

UniProtKB/Swiss-Prot variant pages

Due to maintenance work, this service will be unavailable from Mon Nov 11 17:30 until Tue Nov 12 09:00 CET. Apologies for the inconvenience.

UniProtKB/Swiss-Prot O14686: Variant p.Arg5340Leu

Histone-lysine N-methyltransferase 2D
Gene: KMT2D
Feedback?
Variant information Variant position: help 5340 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Leucine (L) at position 5340 (R5340L, p.Arg5340Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In KABUK1. Any additional useful information about the variant.


Sequence information Variant position: help 5340 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 5537 The length of the canonical sequence.
Location on the sequence: help RYGRHPLMELPLMINPTGCA R SEPKILTHYKRPHTLNSTSM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         RYGRHPLMELPLMINPTGCARSEPKILTHYKRPHTLNSTSM

Mouse                         RYGRHPLMELPLMINPTGCARSEPKILTHYKRPHTLNSTSM
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 5537 Histone-lysine N-methyltransferase 2D
Motif 5337 – 5342 WDR5 interaction motif (WIN)
Helix 5339 – 5341



Literature citations
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome.
Ng S.B.; Bigham A.W.; Buckingham K.J.; Hannibal M.C.; McMillin M.J.; Gildersleeve H.I.; Beck A.E.; Tabor H.K.; Cooper G.M.; Mefford H.C.; Lee C.; Turner E.H.; Smith J.D.; Rieder M.J.; Yoshiura K.; Matsumoto N.; Ohta T.; Niikawa N.; Nickerson D.A.; Bamshad M.J.; Shendure J.;
Nat. Genet. 42:790-793(2010)
Cited for: VARIANTS KABUK1 PHE-5109; HIS-5179; HIS-5214; LEU-5340 AND MET-5464; INVOLVEMENT IN KABUK1; Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.
Hannibal M.C.; Buckingham K.J.; Ng S.B.; Ming J.E.; Beck A.E.; McMillin M.J.; Gildersleeve H.I.; Bigham A.W.; Tabor H.K.; Mefford H.C.; Cook J.; Yoshiura K.; Matsumoto T.; Matsumoto N.; Miyake N.; Tonoki H.; Naritomi K.; Kaname T.; Nagai T.; Ohashi H.; Kurosawa K.; Hou J.W.; Ohta T.; Liang D.; Sudo A.; Morris C.A.; Banka S.; Black G.C.; Clayton-Smith J.; Nickerson D.A.; Zackai E.H.; Shaikh T.H.; Donnai D.; Niikawa N.; Shendure J.; Bamshad M.J.;
Am. J. Med. Genet. A 155A:1511-1516(2011)
Cited for: VARIANTS KABUK1 LEU-1388; ARG-1430; TYR-1471; CYS-5048; PHE-5109; HIS-5179; CYS-5214; HIS-5214; LEU-5340; MET-5464 AND THR-5471;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.